- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High-risk Percutaneous Coronary Intervention in Norway
Total 16 results
-
Sorlandet Hospital HFOslo University Hospital; HoloCare ASRecruitingPercutaneous Coronary Intervention | Chronic Total Occlusion of Coronary ArteryNorway
-
Herlev and Gentofte HospitalAbbottActive, not recruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Coronary Artery CalcificationDenmark, Belgium, Norway, Estonia
-
Boehringer IngelheimCompletedAtrial Fibrillation | Percutaneous Coronary InterventionCanada, United States, Spain, Korea, Republic of, Australia, Germany, Taiwan, Hong Kong, Thailand, United Kingdom, Turkey, Netherlands, Ireland, Hungary, Croatia, Colombia, Israel, Singapore, Italy, New Zealand, Greece, Mexico, Norway, Swed... and more
-
Janssen Scientific Affairs, LLCBayerCompletedAtrial Fibrillation | Percutaneous Coronary InterventionUnited States, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Argentina, Mexico, Bulgaria, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic of, Australia, Canada, Netherlands, Denmark and more
-
Cogentus PharmaceuticalsTerminatedMyocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary InterventionUnited States, France, Canada, Australia, Poland, Germany, Italy, Mexico, Romania, Slovakia, Hungary, Czech Republic, Chile, Bulgaria, Puerto Rico, Ukraine
-
Rene KahnCompletedUltra High Risk for PsychosisSpain, Austria, Germany, Israel, Italy, Netherlands, Norway, Switzerland, United Kingdom
-
Oslo University HospitalUniversity of Oslo; Rigshospitalet, Denmark; University of Oxford; Norwegian SIDS... and other collaboratorsEnrolling by invitationPreeclampsia | High Risk Pregnancy | Hypertensive Disorder of Pregnancy | Premature Preterm Rupture of Membranes | Previous Adverse Obstetric OutcomeNorway
-
Alnylam PharmaceuticalsRecruitingHypertension | High Cardiovascular RiskUnited States, Canada
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingHigh-Risk Neuroblastoma | Patient With Insufficient Response ChemoimmunotherapyFrance, Germany, Israel, Spain, United Kingdom, Belgium, Norway, Sweden, Finland, Australia, Czechia, Italy, Netherlands, Slovenia, Switzerland, Denmark, Greece, Lithuania, Slovakia
-
AstraZenecaThe Cleveland Clinic; IQVIA RDS Inc.CompletedEligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
-
AstraZenecaBristol-Myers Squibb; Hadassah Medical Organization; The TIMI Study GroupCompletedDiabetes Mellitus, Non-Insulin-Dependent | High Risk for Cardiovascular EventUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Thailand, Vietnam, Bulgaria, Korea, Republic of, Brazil, Philippines, Russian Federation, Turkey, Taiwan, Australia, Israel, South Africa, Germany, Japan, Czechia, H... and more
-
BayerRecruitingAcute Non-cardioembolic Ischemic Stroke | Prevention of Ischemic Stroke | High-risk Transient Ischemic AttackUnited States, Switzerland, Belgium, Sweden, Canada, Australia, Taiwan, Spain, Korea, Republic of, Latvia, Israel, Malaysia, Greece, Japan, Turkey, Netherlands, Romania, China, United Kingdom, Portugal, Italy, Brazil, France, Slovakia, ... and more
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Colombia, ... and more